We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |


JAMA. 1966;196(8):731-732. doi:10.1001/jama.1966.03100210101031.
Text Size: A A A
Published online


Oral contraceptives are now known to enhance vaginal yeast growth. A communication in a recent Archives of Dermatology describes the clinical features of 13 patients taking norethynodrel with mestranol in whom yeast vulvovaginitis developed.1 The patients, all of childbearing age, were receiving the drug for birth control. In each instance other predisposing factors such as diabetes mellitus, pregnancy, antibiotic therapy, or condidiasis in the sexual partner were ruled out. The infective agent, Candida albicans, was identified by conventional culture methods, and by a new rapid and efficient technique, the so-called germtube method of identification.

Outstanding features of yeast infection in patients taking oral contraceptives are the tendency for the infection to recur and the frequent failure of conventional therapy. In this series three patients responded to treatment only after discontinuance of the oral contraceptive.

The factors enhancing vaginal yeast growth are probably similar in normal pregnancy and in the


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.